Peripheral blood myeloid-to-lymphoid ratio: a novel indicator for assessing renal and cardiovascular risks in chronic kidney disease patients—a multicenter longitudinal investigation
Open Access
- 12 December 2025
- journal article
- research article
- Published by Springer Nature in European Journal of Medical Research
- Vol. 31 (1)
Abstract
The myeloid-to-lymphoid ratio (MLR) has been associated with adverse outcomes in various clinical settings; however, its prognostic significance in chronicKeywords
Funding Information
- Joint Funds of the National Natural Science Foundation of China (U22A20279)
- key program of the Natural Science Foundation of China (82030023)
- Key project of Chongqing technology development and application program (CSTB2023TIAD-KPX0060)
This publication has 34 references indexed in Scilit:
- Chronic kidney disease ten years after pediatric allogeneic hematopoietic stem cell transplantationKidney International, 2021
- The global burden of chronic kidney diseaseThe Lancet, 2020
- Lineage-Biased Hematopoietic Stem Cells Are Regulated by Distinct NichesDevelopmental Cell, 2018
- From haematopoietic stem cells to complex differentiation landscapesNature, 2018
- Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney diseaseNature Medicine, 2016
- Uremic toxins impair human bone marrow-derived mesenchymal stem cells functionality in vitroExperimental and Toxicologic Pathology, 2014
- Klotho Deficiency Disrupts Hematopoietic Stem Cell Development and ErythropoiesisThe American Journal of Pathology, 2014
- Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune responseNature Reviews Immunology, 2011
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial InfarctionJAMA, 2009
- Low circulating CD34+ cell count is associated with poor prognosis in chronic hemodialysis patientsKidney International, 2008